BMRN logo

BioMarin Pharmaceutical (BMRN) Short term debt

Annual short term debt:

$7.57M-$495.08M(-98.49%)
December 31, 2024

Summary

  • As of today (July 1, 2025), BMRN annual short term debt is $7.57 million, with the most recent change of -$495.08 million (-98.49%) on December 31, 2024.
  • During the last 3 years, BMRN annual short term debt has fallen by -$2.89 million (-27.62%).
  • BMRN annual short term debt is now -98.49% below its all-time high of $502.66 million, reached on December 31, 2023.

Performance

BMRN Short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNbalance sheet metrics

quarterly short term debt:

$6.31M-$1.26M(-16.70%)
March 31, 2025

Summary

  • As of today (July 1, 2025), BMRN quarterly short term debt is $6.31 million, with the most recent change of -$1.26 million (-16.70%) on March 31, 2025.
  • Over the past year, BMRN quarterly short term debt has dropped by -$496.62 million (-98.75%).
  • BMRN quarterly short term debt is now -98.75% below its all-time high of $505.53 million, reached on June 30, 2024.

Performance

BMRN quarterly short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNbalance sheet metrics

Short term debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

BMRN Short term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-98.5%-98.8%
3 y3 years-27.6%-41.7%
5 y5 years-98.0%-98.3%

BMRN Short term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-98.5%at low-98.8%at low
5 y5-year-98.5%at low-98.8%at low
alltimeall time-98.5%>+9999.0%-98.8%>+9999.0%

BMRN Short term debt History

DateAnnualQuarterly
Mar 2025
-
$6.31M(-16.7%)
Dec 2024
$7.57M(-98.5%)
$7.57M(-6.0%)
Sep 2024
-
$8.06M(-98.4%)
Jun 2024
-
$505.53M(+0.5%)
Mar 2024
-
$502.93M(+0.1%)
Dec 2023
$502.66M(+4744.9%)
$502.66M(-0.0%)
Sep 2023
-
$502.72M(+5961.3%)
Jun 2023
-
$8.29M(-10.3%)
Mar 2023
-
$9.25M(-10.8%)
Dec 2022
$10.38M(-0.9%)
$10.38M(+12.5%)
Sep 2022
-
$9.23M(-13.1%)
Jun 2022
-
$10.61M(-2.0%)
Mar 2022
-
$10.83M(+3.5%)
Dec 2021
$10.46M(-11.0%)
$10.46M(+8.3%)
Sep 2021
-
$9.66M(-12.4%)
Jun 2021
-
$11.02M(-1.8%)
Mar 2021
-
$11.23M(-4.5%)
Dec 2020
$11.75M(-96.8%)
$11.75M(-96.9%)
Sep 2020
-
$385.22M(+1.0%)
Jun 2020
-
$381.49M(+1.4%)
Mar 2020
-
$376.37M(+1.0%)
Dec 2019
$372.58M(>+9900.0%)
$372.58M(+3543.8%)
Sep 2019
-
$10.22M(+0.6%)
Jun 2019
-
$10.16M(+10.4%)
Mar 2019
-
$9.21M(>+9900.0%)
Dec 2018
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2018
-
$374.23M(+1.2%)
Jun 2018
-
$369.75M(+1.2%)
Mar 2018
-
$365.33M(+1.2%)
Dec 2017
$360.95M(+1505.8%)
$360.95M(+1504.6%)
Mar 2017
-
$22.50M(+0.1%)
Dec 2016
$22.48M
$22.48M(+0.1%)
Sep 2016
-
$22.46M(-8.0%)
DateAnnualQuarterly
Jun 2016
-
$24.42M(+4.5%)
Dec 2012
$23.36M(-67.0%)
$23.36M(-0.3%)
Sep 2012
-
$23.44M(0.0%)
Jun 2012
-
$23.44M(-0.1%)
Mar 2012
-
$23.45M(-66.6%)
Mar 2009
-
$70.32M(-0.6%)
Dec 2008
$70.74M(+942.3%)
$70.74M(+1116.3%)
Jun 2008
-
$5.82M(-4.1%)
Mar 2008
-
$6.07M(-7.4%)
Sep 2007
-
$6.55M(-3.5%)
Jun 2007
-
$6.79M(-0.0%)
Mar 2007
-
$6.79M(-0.0%)
Dec 2006
$6.79M(-40.1%)
$6.79M(0.0%)
Sep 2006
-
$6.79M(+1.2%)
Jun 2006
-
$6.71M(-75.2%)
Mar 2006
-
$27.05M(+138.6%)
Dec 2005
$11.34M(-73.5%)
$11.34M(-3.1%)
Sep 2005
-
$11.70M(-3.7%)
Jun 2005
-
$12.14M(-51.5%)
Mar 2005
-
$25.06M(-41.5%)
Dec 2004
$42.80M(+2590.4%)
$42.80M(-12.2%)
Sep 2004
-
$48.75M(-16.3%)
Jun 2004
-
$58.23M(+3289.3%)
Mar 2002
-
$1.72M(+8.0%)
Dec 2001
$1.59M(+5792.6%)
$1.59M(+1574.7%)
Sep 2001
-
$95.00K(-3.1%)
Jun 2001
-
$98.00K(+237.9%)
Mar 2001
-
$29.00K(+7.4%)
Dec 2000
$27.00K(+3.8%)
$27.00K(-3.6%)
Sep 2000
-
$28.00K(-3.4%)
Jun 2000
-
$29.00K(+11.5%)
Mar 2000
-
$26.00K(0.0%)
Dec 1999
$26.00K
$26.00K

FAQ

  • What is BioMarin Pharmaceutical annual short term debt?
  • What is the all time high annual short term debt for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical annual short term debt year-on-year change?
  • What is BioMarin Pharmaceutical quarterly short term debt?
  • What is the all time high quarterly short term debt for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical quarterly short term debt year-on-year change?

What is BioMarin Pharmaceutical annual short term debt?

The current annual short term debt of BMRN is $7.57M

What is the all time high annual short term debt for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high annual short term debt is $502.66M

What is BioMarin Pharmaceutical annual short term debt year-on-year change?

Over the past year, BMRN annual short term debt has changed by -$495.08M (-98.49%)

What is BioMarin Pharmaceutical quarterly short term debt?

The current quarterly short term debt of BMRN is $6.31M

What is the all time high quarterly short term debt for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high quarterly short term debt is $505.53M

What is BioMarin Pharmaceutical quarterly short term debt year-on-year change?

Over the past year, BMRN quarterly short term debt has changed by -$496.62M (-98.75%)
On this page